Cargando…
IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt(+) T(reg) generation via enhanced IL‐6 induction
IL‐33 is a member of the IL‐1 family. By binding to its receptor ST2 (IL‐33R) on mast cells, IL‐33 induces the MyD88‐dependent activation of the TAK1‐IKK2 signalling module resulting in activation of the MAP kinases p38, JNK1/2 and ERK1/2, and of NFκB. Depending on the kinases activated in these pat...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044339/ https://www.ncbi.nlm.nih.gov/pubmed/33427298 http://dx.doi.org/10.1111/imm.13305 |
_version_ | 1783678462020550656 |
---|---|
author | Drube, Sebastian Müller, Sylvia Weber, Franziska Wegner, Philine Böttcher‐Loschinski, Romy Gaestel, Matthias Hutloff, Andreas Kamradt, Thomas Andreas, Nico |
author_facet | Drube, Sebastian Müller, Sylvia Weber, Franziska Wegner, Philine Böttcher‐Loschinski, Romy Gaestel, Matthias Hutloff, Andreas Kamradt, Thomas Andreas, Nico |
author_sort | Drube, Sebastian |
collection | PubMed |
description | IL‐33 is a member of the IL‐1 family. By binding to its receptor ST2 (IL‐33R) on mast cells, IL‐33 induces the MyD88‐dependent activation of the TAK1‐IKK2 signalling module resulting in activation of the MAP kinases p38, JNK1/2 and ERK1/2, and of NFκB. Depending on the kinases activated in these pathways, the IL‐33‐induced signalling is essential for production of IL‐6 or IL‐2. This was shown to control the dichotomy between RORγt(+) and Helios(+) T(regs), respectively. SCF, the ligand of c‐Kit (CD117), can enhance these effects. Here, we show that IL‐3, another growth factor for mast cells, is essential for the expression of ICOS‐L on BMMCs, and costimulation with IL‐3 potentiated the IL‐33‐induced IL‐6 production similar to SCF. In contrast to the enhanced IL‐2 production by SCF‐induced modulation of the IL‐33 signalling, IL‐3 blocked the production of IL‐2. Consequently, IL‐3 shifted the IL‐33‐induced T(reg) dichotomy towards RORγt(+) T(regs) at the expense of RORγt(−) Helios(+) T(regs). However, ICOS‐L expression was downregulated by IL‐33. In line with that, ICOS‐L did not play any important role in the T(reg) modulation by IL‐3/IL‐33‐activated mast cells. These findings demonstrate that different from the mast cell growth factor SCF, IL‐3 can alter the IL‐33‐induced and mast cell‐dependent regulation of T(reg) subpopulations by modulating mast cell‐derived cytokine profiles. |
format | Online Article Text |
id | pubmed-8044339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80443392021-04-16 IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt(+) T(reg) generation via enhanced IL‐6 induction Drube, Sebastian Müller, Sylvia Weber, Franziska Wegner, Philine Böttcher‐Loschinski, Romy Gaestel, Matthias Hutloff, Andreas Kamradt, Thomas Andreas, Nico Immunology Original Articles IL‐33 is a member of the IL‐1 family. By binding to its receptor ST2 (IL‐33R) on mast cells, IL‐33 induces the MyD88‐dependent activation of the TAK1‐IKK2 signalling module resulting in activation of the MAP kinases p38, JNK1/2 and ERK1/2, and of NFκB. Depending on the kinases activated in these pathways, the IL‐33‐induced signalling is essential for production of IL‐6 or IL‐2. This was shown to control the dichotomy between RORγt(+) and Helios(+) T(regs), respectively. SCF, the ligand of c‐Kit (CD117), can enhance these effects. Here, we show that IL‐3, another growth factor for mast cells, is essential for the expression of ICOS‐L on BMMCs, and costimulation with IL‐3 potentiated the IL‐33‐induced IL‐6 production similar to SCF. In contrast to the enhanced IL‐2 production by SCF‐induced modulation of the IL‐33 signalling, IL‐3 blocked the production of IL‐2. Consequently, IL‐3 shifted the IL‐33‐induced T(reg) dichotomy towards RORγt(+) T(regs) at the expense of RORγt(−) Helios(+) T(regs). However, ICOS‐L expression was downregulated by IL‐33. In line with that, ICOS‐L did not play any important role in the T(reg) modulation by IL‐3/IL‐33‐activated mast cells. These findings demonstrate that different from the mast cell growth factor SCF, IL‐3 can alter the IL‐33‐induced and mast cell‐dependent regulation of T(reg) subpopulations by modulating mast cell‐derived cytokine profiles. John Wiley and Sons Inc. 2021-01-27 2021-05 /pmc/articles/PMC8044339/ /pubmed/33427298 http://dx.doi.org/10.1111/imm.13305 Text en © 2021 The Authors. Immunology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Drube, Sebastian Müller, Sylvia Weber, Franziska Wegner, Philine Böttcher‐Loschinski, Romy Gaestel, Matthias Hutloff, Andreas Kamradt, Thomas Andreas, Nico IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt(+) T(reg) generation via enhanced IL‐6 induction |
title | IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt(+) T(reg) generation via enhanced IL‐6 induction |
title_full | IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt(+) T(reg) generation via enhanced IL‐6 induction |
title_fullStr | IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt(+) T(reg) generation via enhanced IL‐6 induction |
title_full_unstemmed | IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt(+) T(reg) generation via enhanced IL‐6 induction |
title_short | IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt(+) T(reg) generation via enhanced IL‐6 induction |
title_sort | il‐3 is essential for icos‐l stabilization on mast cells, and sustains the il‐33‐induced rorγt(+) t(reg) generation via enhanced il‐6 induction |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044339/ https://www.ncbi.nlm.nih.gov/pubmed/33427298 http://dx.doi.org/10.1111/imm.13305 |
work_keys_str_mv | AT drubesebastian il3isessentialforicoslstabilizationonmastcellsandsustainstheil33inducedrorgttreggenerationviaenhancedil6induction AT mullersylvia il3isessentialforicoslstabilizationonmastcellsandsustainstheil33inducedrorgttreggenerationviaenhancedil6induction AT weberfranziska il3isessentialforicoslstabilizationonmastcellsandsustainstheil33inducedrorgttreggenerationviaenhancedil6induction AT wegnerphiline il3isessentialforicoslstabilizationonmastcellsandsustainstheil33inducedrorgttreggenerationviaenhancedil6induction AT bottcherloschinskiromy il3isessentialforicoslstabilizationonmastcellsandsustainstheil33inducedrorgttreggenerationviaenhancedil6induction AT gaestelmatthias il3isessentialforicoslstabilizationonmastcellsandsustainstheil33inducedrorgttreggenerationviaenhancedil6induction AT hutloffandreas il3isessentialforicoslstabilizationonmastcellsandsustainstheil33inducedrorgttreggenerationviaenhancedil6induction AT kamradtthomas il3isessentialforicoslstabilizationonmastcellsandsustainstheil33inducedrorgttreggenerationviaenhancedil6induction AT andreasnico il3isessentialforicoslstabilizationonmastcellsandsustainstheil33inducedrorgttreggenerationviaenhancedil6induction |